NL
LLY icon

NorthAvenue LLC’s Eli Lilly LLY Stock Holding History

NorthAvenue LLC’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.2K Buy
21
+12
+133% +$12.3K 0.02% 102
2026
Q1 		$8.28K Hold
9
– – 0.01% 140
2025
Q4 		$9.67K Buy
+9
New +$8.61K 0.01% 138

Other funds holding LLY

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

NorthAvenue LLC's LLY Position: Q2 2026 in Review

NorthAvenue LLC increased its Eli Lilly (LLY) stake by 133% in Q2 2026, buying an estimated $12.3K and bringing the position to 21 shares worth $25.2K. The position accounts for 0.02% of the portfolio, ranked #102.

NorthAvenue LLC first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 1,143 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • NorthAvenue LLC held 21 shares of Eli Lilly worth $25.2K as of Q2 2026.
  • NorthAvenue LLC bought 12 Eli Lilly shares in Q2 2026, an estimated $12.3K.
  • Eli Lilly made up 0.02% of NorthAvenue LLC's portfolio in Q2 2026, its #102 holding.
  • NorthAvenue LLC first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 1,143 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on NorthAvenue LLC's 13F filing for Q2 2026, filed 21 Jul 2026.